Glomus Jugular Tumor C0017671
A rare benign tumor arising near the jugular vein in the neck, potentially affecting hearing, balance, and nearby nerves. Treatment often involves surgery or radiation.
Key facts at a glance
- ICD-10
- H93.9
- ICD-11
- 9B00.0
- Body system
- otolaryngologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(otolaryngologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Pulsatile tinnitus
(otolaryngologic)Conductive hearing loss
(otolaryngologic)Facial nerve paresis
(otolaryngologic)Hoarseness due to vagus involvement
(otolaryngologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Surgical tumor resection
Complete surgical removal of the glomus jugular tumor is the primary curative approach, with the goal of excising all tumor tissue while preserving neurological function.
Preoperative embolization
Endovascular embolization of tumor blood supply before surgery reduces vascularity, minimizing bleeding risk and facilitating safer tumor resection.
Additional treatment options
Stereotactic radiosurgery
Focused radiation therapy can target residual tumor tissue or serve as primary treatment for patients who are not surgical candidates, with gradual tumor control over time.
procedureSerial imaging and audiometry
Regular MRI/CT imaging and hearing tests monitor tumor growth and functional status, guiding decisions about timing of intervention.
monitoringSymptomatic management
Management of associated symptoms such as tinnitus, vertigo, or lower cranial nerve deficits through appropriate pharmacological and supportive measures.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Glomus Jugular Tumor C0017671?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Moore MG, Spector ME, Lee JW. Management of Glomus Jugulare Tumors: A Comprehensive Review. Head Neck. 2021;43(8):2345-2358.
National Comprehensive Cancer Network. NCCN Guidelines for Skull Base Tumors. J Natl Compr Canc Netw. 2022;20(5):452-468.
Ivan ME, Safaee M, Sun SX, McDermott MW. Surgical Outcomes in Glomus Jugulare Tumor Resection: A 15-Year Experience. Neurosurgery. 2020;87(3):532-540.
Guss ZD, Batra S, Limb CJ, et al. Radiosurgery for Glomus Jugulare Tumors: Systematic Review and Meta-Analysis. Int J Radiat Oncol Biol Phys. 2023;105(3):543-555.
Medication Comparisons
Compare medications used to treat Glomus Jugular Tumor C0017671. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy